Wonder Drug, page-7

"Graham Kelly is the CEO of Noxopharm, and they’ve got basically one drug which is an anti-cancer drug called Veyonda which Graham found 30 years ago himself and has been trying to develop it ever since. The story of that is quite interesting in itself really but he has now got three trials going on for various types of cancer that couple the drug with others with the idea of extending life and the idea of the business, I guess, is to set up an auction for their drug sometime hopefully next year where two or three large pharmaceutical businesses bid for Noxopharm’s drug. So they’re in phase two trials, they’re not going to go to phase three trials, they’re going to sell it before then and so the payoff hopefully, according to Graham, is 12 months off."
disallowed link/investment-news/noxopharms-hopes-for-a-big-pharma-auction/149484

30 years RBX. Remember when GK was telling the market that phase 111 will be done and dusted  by 2018. And yet here we are....... almost five years on and still waiting for a phase II trial to even start yet alone "marketing approval by 2022".   3o years.... and posters wonder why so many are skeptical of the never ending promises and bold claims that never eventuate.

“We expect to know by end of 2017 of the success of our mission,” the company reported this month in its roadshow presentation.
“We aim to be in a registration study by end of 2018 [and] to have marketing approval by 2022.”Dr Kelly Stockheads 2017 https://unauthorised investment adv...ts-nox66-cancer-drug-trial-results-christmas/